Company: LENZ
Filing Date: 2025-04-04
Form Type: POS AM
Source: 0001628280-25-016815
Chunk: 17

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-04
Form: POS AM
Chunk 17
---
 stockholder will in fact sell any or all of such Common Stock. In addition, the selling stockholder may sell, transfer or otherwise dispose of, at any time and from time to time, the Common Stock in transactions exempt from the registration requirements of the Securities Act after the date of this prospectus. Information about the selling stockholders, including those listed below, may change over time. Since the effectiveness of the initial prospectus, certain securityholders may have sold or otherwise transferred their securities registered thereunder. For purposes of this table, we have assumed that the selling stockholder will have sold all of the shares of Common Stock covered by this prospectus upon the completion of the offering.

Selling stockholder information for each additional selling stockholder, if any, will be set forth by a prospectus supplement to the extent required prior to the time of any offer or sale of such selling stockholder’s shares pursuant to this prospectus. Any prospectus supplement may add, update, substitute, or change the information contained in this prospectus, including the identity of each selling stockholder and the number of shares registered on its behalf. A selling stockholder may sell or otherwise transfer all, some or none of such shares in this offering. See “ Plan of Distribution .”

| Name of Selling Stockholder           |     | Common Stock Beneficially Owned Prior to Offering |           |     |        |     | Number of Shares of Common Stock Being Offered |           |     |         |     | Common Stock Beneficially Owned After the Offered Shares of Common Stock are Sold |         |     |     |   |
|                                       |     |                                                   |           |     | Number |     |                                                |           |     | Percent |     |                                                                                   |         |     |     |   |
| Ridgeback Capital Investments L.P.(1) |     |                                                   | 1,901,875 |     |        |     |                                                | 1,578,947 |     |         |     |                                                                                   | 322,928 |     | 1.2 | % |

__________________

* Less than 1%

(1) Consists of 1,578,947 shares of common stock purchased in the July 2024 PIPE Financing. Ridgeback Capital Investments LLC, or RCI, is the general partner of Ridgeback Capital Investments L.P., or RCILP. Pursuant to an investment management agreement, Ridgeback Capital Management, LLC, or RCM, maintains investment and voting power with respect to the securities